CDTVSVTGN• 3 Months (Normalized)
CDT vs VTGN (CDT Equity Inc. vs Vistagen Therapeutics Inc.)
Showing Closing Date Range from Jun 27 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CDT Performance $0.14
-97.68%
CDT Equity Inc.
Normalized Baseline0.00%
VTGN Performance $0.37
-51.32%
Vistagen Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin VTGN LEADS
-46.36 pts
VTGN outperforming by 46.36 percentage points
CDTVTGN
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CDT VTGN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(61 dates)
| Date | CDT Price | CDT Gain (%) | VTGN Price | VTGN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $0.14 | -97.68% | $0.37 | -51.32% | -46.36% |
| Sep 22, 2026 | $0.14 | -97.56% | $0.25 | -67.11% | -30.45% |
| Sep 21, 2026 | $0.15 | -97.36% | $0.23 | -69.74% | -27.62% |
| Sep 18, 2026 | $0.17 | -97.02% | $0.24 | -68.42% | -28.60% |
| Sep 17, 2026 | $0.19 | -96.74% | $0.23 | -69.74% | -27.00% |
| Sep 16, 2026 | $0.20 | -96.60% | $0.23 | -69.74% | -26.86% |
| Sep 15, 2026 | $0.20 | -96.52% | $0.24 | -68.42% | -28.10% |
| Sep 14, 2026 | $0.22 | -96.24% | $0.24 | -68.00% | -28.24% |
| Sep 11, 2026 | $0.25 | -95.71% | $0.24 | -68.42% | -27.29% |
| Sep 10, 2026 | $0.35 | -94.08% | $0.24 | -68.42% | -25.66% |
| Sep 09, 2026 | $0.60 | -89.71% | $0.24 | -68.42% | -21.29% |
| Sep 08, 2026 | $0.62 | -89.42% | $0.24 | -68.42% | -21.00% |
| Sep 04, 2026 | $0.63 | -89.28% | $0.24 | -68.42% | -20.86% |
| Sep 03, 2026 | $0.75 | -87.15% | $0.25 | -67.11% | -20.04% |
| Sep 02, 2026 | $0.91 | -84.39% | $0.25 | -67.11% | -17.28% |
Page 1 of 5